Postoperative pulmonary complications - Still room for improvement
The most common complications after surgery are postoperative bleeding, sepsis and cardiac and pulmonary complications.5 The last of these complications is particularly relevant to the anaesthetic community because ventilation is under the control of the anaesthetist during the intraoperative period. The large cross-sectional LAS VEGAS study, partially funded by the European Society of Anaesthesiology and published in this issue of the European Journal of Anaesthesiology,6 highlights a number of important aspects in this area: the incidence of postoperative pulmonary complications is high (19%); patients at increased risk of postoperative pulmonary complication have a longer duration of hospital stay (4 versus 1 day for low-risk patients); these patients have a higher mortality rate at 28 days (1.7 versus 0.2%); and modifying the intraoperative ventilation regimen, beyond modification of the intraoperative peak pressure, seems to be of limited benefit for these patients.
Some aspects of the LAS VEGAS study deserve further comments. One is its large size. In all, 146 centres in and outside Europe participated in the study. Thus, our ability to generalise the study results is high. Another is the use of a validated risk score for assessment of the risk of pulmonary complications, the Assess Respiratory Risk in Surgical Patients in Catalonia score. It has a high predictive value (area under the curve 0.88).7–9 It includes straightforward and easily identifiable predictors such as age, preoperative peripherial oxygen saturation, respiratory infection in the last month, preoperative anaemia, site of surgical incision, duration of surgery and urgency of procedure. Thus, the study's findings have a high level of validity. Another aspect to be highlighted is that the LAS VEGAS study assessed outcomes that are important for perioperative healthcare management. The finding that 28% of all patients were at risk of postoperative pulmonary complications has consequences for the management of postoperative care. As 1.6% of patients are likely to develop postoperative respiratory failure, monitored and noninvasive ventilation should be planned before surgery in patients at highest risk to avoid unavailability of beds in intermediate or ICUs.
Although highly valid and generally applicable, the results of the LAS VEGAS study should be interpreted with some caution. The secondary postoperative outcome of the LAS VEGAS study is a composite endpoint. It includes unplanned supplemental oxygen administration, respiratory failure, invasive mechanical ventilation, acute respiratory distress syndrome, pneumonia and pneumothorax. Some of these endpoints, such as pneumothorax, have clear definitions, whereas some others that relate to therapeutic interventions (e.g. supplemental oxygen administration) may include nonstandardised components such as local criteria to decide on the need for administration of additional oxygen. As a result, there is some variability in outcome definition that may add uncertainty around incidence measurement.10–12
Although the LAS VEGAS study identifies a number of pulmonary adverse outcomes, some are also missing. These are atelectasis, diaphragmatic dysfunction, retention of bronchial secretions, (micro) aspiration, pulmonary oedema and pleural effusion. Many of the included and not included postoperative pulmonary complications can be related to anaesthetic management, such as fluid or pain management, but some relate to unidentified acute cardiac dysfunction.